Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 90 entries
View as:

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03673306 Org: User:
Start: 01/16/17 End: 12/31/23 Due: 12/31/24

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT04379817 Org: User:
Start: 02/25/20 End: 05/23/24 Due: 05/23/25

Double-blind Study to Assess effectIveness of Pectoral Nerves Block After Breast Surgery on Piritramide Consumption

Phase: N/A Priority: Normal
NCT ID: NCT02655965 Org: User:
Start: 05/31/16 End: 01/20/21 Due: 01/20/22

Inferior Epigastric Lymph Node in Colorectal Carcinosis

Phase: N/A Priority: Normal
NCT ID: NCT04966715 Org: User:
Start: 02/03/22 End: 01/31/24 Due: 01/31/25

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)

Phase: N/A Priority: Normal
NCT ID: NCT01929616 Org: User:
Start: 08/31/13 End: 06/17/19 Due: 06/17/20

Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia

Phase: N/A Priority: Normal
NCT ID: NCT01658956 Org: User:
Start: 07/31/12 End: 07/31/15 Due: 07/31/16

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01481701 Org: User:
Start: 10/31/08 End: 05/31/14 Due: 05/31/15

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

Phase: N/A Priority: Normal
NCT ID: NCT05075538 Org: User:
Start: 12/01/21 End: 01/08/24 Due: 01/08/25

ProCaLung: Project on Cancer of the Lung

Phase: N/A Priority: Normal
NCT ID: NCT04726358 Org: User:
Start: 10/01/21 End: 03/01/25 Due: 03/01/26

Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01290926 Org: User:
Start: 02/28/11 End: 01/31/16 Due: 01/31/17

Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features

Phase: N/A Priority: Normal
NCT ID: NCT05865756 Org: User:
Start: 04/01/21 End: 09/01/24 Due: 09/01/25

PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06059469 Org: User:
Start: 05/30/22 End: 09/30/24 Due: 09/30/25

To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT

Phase: N/A Priority: Normal
NCT ID: NCT05891470 Org: User:
Start: 09/01/23 End: 02/02/26 Due: 02/02/27

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Phase: N/A Priority: Normal
NCT ID: NCT01301040 Org: User:
Start: 03/31/11 End: 03/31/16 Due: 03/31/17

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01834469 Org: User:
Start: 03/31/13 End: 10/31/14 Due: 10/31/15

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02053597 Org: User:
Start: 10/31/14 End: 07/31/15 Due: 07/31/16

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

Phase: N/A Priority: Normal
NCT ID: NCT01686880 Org: User:
Start: 09/30/12 End: 01/31/15 Due: 01/31/16

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Phase: N/A Priority: Normal
NCT ID: NCT06925984 Org: User:
Start: 05/01/25 End: 05/01/30 Due: 05/01/31

Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01591590 Org: User:
Start: 06/30/12 End: 09/25/21 Due: 09/25/22

NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG

Phase: N/A Priority: Normal
NCT ID: NCT02027831 Org: User:
Start: 12/31/13 End: 10/31/14 Due: 10/31/15

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00614978 Org: User:
Start: 01/31/08 End: 06/30/11 Due: 06/30/12

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Phase: N/A Priority: Normal
NCT ID: NCT06150898 Org: User:
Start: 05/12/25 End: 10/31/27 Due: 10/31/28

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Phase: N/A Priority: Normal
NCT ID: NCT00199173 Org: User:
Start: - End: 01/31/10 Due: 01/31/11

Advanced Cancer Patients' and Their Primary Caregivers' Willingness to Communicate About Advance Care Planning (ACP)

Phase: N/A Priority: Normal
NCT ID: NCT05426330 Org: User:
Start: 10/04/21 End: 10/04/24 Due: 10/04/25

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01554943 Org: User:
Start: 07/31/10 End: 08/31/13 Due: 08/31/14